Iclusig

Home/Tag: Iclusig

FDA asks ARIAD to suspend marketing and sales of Iclusig (ponatinib)

The U.S. Food and Drug Administration (FDA) has asked ARIAD Pharmaceuticals, the manufacturer of Iclusig (ponatinib) to suspend marketing and sales of ponatinib because of the risk of life-threatening blood clots and severe narrowing of [...]

By |2019-09-20T11:38:58-04:00November 1st, 2013|Drug Treatment, News|
Go to Top